ANCA-negative EGPA may instead have a mucosal/barrier dysfunction origin supported by the association with barrier protein GPA33 and shared genetic architecture with inflammatory bowel diseases. Here, GPA33 is linked to eosinophilic granulomatosis with polyangiitis.